Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

Elevation Oncology

Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
2019
11-50
New York, New York, United States
  • Drug Discovery and Development
  • Oncology (Cancer)
  • Personalized Medicine Technologies
  • Pharmaceuticals Packaging

Investment Funding

Last Funding Stage

Post-IPO Equity

Total Funding Amount

198.M

Last Funding Amount

50.M

Last Funding Date

08-06-2023

Startup Stage

M&A

Lead Investors

Cormorant Asset Management, Vivo Capital, Samsara BioCapital, Vertex Ventures HC, Qiming Venture Partners USA

People

Founders

Something missing or incorrect on this page? Help us enrich this information